Kidney Transplant Rejection: Warning Signs, Diagnosis and Treatment

A routine mini-incision laparoscopic transplant package costs approximately USD 13,000-14,000, with an additional USD 3,000 for a fully robotic transplant. Donor selection starts with a related donor within the immediate family, confirmed by DNA testing, with extended family only considered if no closer relative is eligible, alongside blood-group and basic health workup. Transplant is generally advised once creatinine exceeds 7, with signs of fluid overload or hyperkalaemia, shrunken kidneys with reduced urine output, and a raised PTH indicating the kidneys will not recover, with an practical age ceiling of around 80 depending on the patient's actual physiological fitness.

These patients do fairly well. CD4 count is checked and optimised before travel, with good medical management started well ahead of transplant so patients only travel once they fall into a suitable category. The immediate transplant risk in HIV-positive patients is similar to other patients, though later opportunistic-infection-related complications run somewhat higher, so immunosuppression is adjusted accordingly, for example avoiding routine ATG in favour of a gentler induction agent so immunity is not suppressed as heavily.

Yes, blood group-incompatible transplants are done routinely, though they remain the second choice after a compatible donor. The recipient's antibody titre against the donor's blood group determines eligibility: titres up to 1:8 are essentially as good as a compatible transplant, and even up to 1:64 respond to one or two sessions of plasmapheresis. Higher titres, above 1:128, need immunoadsorption column filtration to bring the level down before proceeding. The success rate is good but runs slightly below a fully compatible transplant, with roughly one in 50 patients experiencing hyperacute rejection.

Yes, HLA incompatibility alone is not a major problem, even between spouses with no HLA match at all. What actually determines eligibility is the cross match: a negative CDC and flow cross match clears the way for transplant. If CDC is negative but flow is positive, donor-specific antibody testing by the single antigen bead method quantifies the real risk, an MFI reading up to roughly 1,500-2,000 is not a concern, while higher readings call for plasmapheresis first. The key requirement is simply that there should be no antibodies against that particular HLA antigen.

Whenever a brain-dead donor is identified anywhere in Delhi NCR, India's national organ transplant authority (NOTTO) is notified and coordinates two brain stem death declarations roughly two hours apart, made jointly by the primary caregiver and a neurointensivist or equivalent specialist. Once the family consents, NOTTO allocates the organ from its waiting list strictly by turn order across hospitals, no single centre can claim it outside that process. From the first declaration to organ harvest is roughly a 12-hour process, with the recipient's dialysis and cross-match run in parallel so the transplant can proceed within six to twelve hours of harvest.

A slow, creeping rise in creatinine from a stable post-transplant baseline, and new protein appearing in urine routine tests. These are the earliest practical clues that prompt a kidney biopsy to check for rejection.

Not usually. Rejection is typically a gradual process rather than an overnight crisis, and can often be managed initially through the patient's local nephrologist, with biopsy results and treatment coordinated remotely, since many of the required medicines are now available outside India too.